CYNTHIA MOSSER: Open Payments
NPI 1790940088 · MEDFORD, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$443 in 10 payments from 5 companies in 2025. Trend: 2023 $371 · 2024 $472 · 2025 $443
Food & beverage: $443
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $235 |
| Regeneron Healthcare Solutions, Inc. | 2 | $62 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $61 |
| Madrigal Pharmaceuticals | 2 | $54 |
| GlaxoSmithKline, LLC. | 1 | $30 |
Products named: Wegovy, DUPIXENT, GLASSIA, REZDIFFRA, Ozempic, NUCALA, Rybelsus.
Industry payments across OR — which companies pay providers there.
